Remove Drug Delivery Remove Drug Delivery Systems Remove Licensing
article thumbnail

Biogen licenses subcutaneous drug delivery system for neurological drugs

Outsourcing Pharma

Biogen partners with Alcyone to gain access to ThecaFlex, which is able to deliver therapies into the intrathecal space.

article thumbnail

Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management

The Pharma Data

In addition to its pharmaceutical, medical device, advanced diagnostics, medical supply, medical technologies, neurosciences, and health and human service divisions, the Company has global exclusivity to license the patented and patent-pending TABMELT ® sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Subcutaneous Medications and Drug Delivery Systems

Roots Analysis

Several Technology Providers, with Proprietary Platforms, have Emerged as Key Enablers Several technology developers have licensed their platforms to other pharmaceutical companies for developing subcutaneous formulation of their approved / pipeline products.

article thumbnail

Leveraging a Drug Patent Portfolio for Success

Drug Patent Watch

This includes novel drug delivery systems, extended-release formulations, or unique combinations of ingredients that enhance efficacy or reduce side effects. Methods of Treatment These patents protect specific ways of using a drug to treat particular conditions.

Drugs 92